Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,94 USD | +0,77% | -0,76% | +12,25% |
03/04 | ALDEYRA THERAPEUTICS, INC. : Oppenheimer herziet advies naar Kopen | ZM |
28/03 | Transcript : Aldeyra Therapeutics, Inc. - Special Call |
Omzet 2024 * | 28,43 mln. 26,56 mln. | Omzet 2025 * | 22,31 mln. 20,84 mln. | Marktkapitalisatie | 234 mln. 219 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -1 mln. -934K | Nettowinst (verlies) 2025 * | -23 mln. -21,48 mln. | EV/omzet 2024 * | 8,23 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 10,5 x |
K/w-verhouding 2024 * |
-78,8
x | K/w-verhouding 2025 * |
-10,4
x | Werknemers | 10 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 81,52% |
Recentste transcriptie over Aldeyra Therapeutics, Inc.
1 dag | +0,77% | ||
1 week | -0,76% | ||
Lopende maand | +20,49% | ||
1 maand | +35,86% | ||
3 maanden | +31,33% | ||
6 maanden | +147,80% | ||
Lopend jaar | +12,25% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Todd Brady
CEO | Chief Executive Officer | 52 | 01-09-05 |
Bruce Greenberg
DFI | Director of Finance/CFO | 56 | 01-12-19 |
Caitlin Pazzano
PRN | Corporate Officer/Principal | - | 01-01-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gary Phillips
BRD | Director/Board Member | 58 | 01-05-09 |
Martin Joyce
BRD | Director/Board Member | 70 | 01-10-13 |
Ben Bronstein
BRD | Director/Board Member | 74 | 01-06-10 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 34 M€ | +2,35% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-04-24 | 3,94 | +0,77% | 570 590 |
23-04-24 | 3,91 | -0,51% | 452 310 |
22-04-24 | 3,93 | +1,81% | 372 085 |
19-04-24 | 3,86 | -3,02% | 429 655 |
18-04-24 | 3,98 | +0,25% | 432 657 |
uitgestelde koers Nasdaq, 24 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+12,25% | 232 mln. | |
-1,51% | 105 mld. | |
+3,22% | 97,5 mld. | |
+1,86% | 22,19 mld. | |
-16,53% | 21,33 mld. | |
-8,49% | 18,68 mld. | |
-42,33% | 16,6 mld. | |
-20,09% | 14,52 mld. | |
+5,47% | 14,09 mld. | |
+28,85% | 10,99 mld. |